Market Overview

Piper Jaffray Reiterates Overweight Rating, $91 PT on Mednax

Related MD
Benzinga's Top Initiations
MEDNAX Announces Acquisition of Large Anesthesiology Practice in New Jersey

In a report published Wednesday, Piper Jaffray & Co. reiterated its Overweight rating and $91.00 price target on Mednax (NYSE: MD) .

Piper Jaffray noted, “This morning, MEDNAX announced the acquisition of Anesthesiologists Associated and Pediatric Surgical and Associates. The anesthesia practice adds 34 anesthesiologists, 100 anesthetists and 24 other clinical and administrative staff, while the pediatric surgery practice adds six pediatric surgeons and 15 other clinical and administrative staff. Both acquisitions were ongoing over the last several months and became effective on December 31, 2012. MD will host a conference call on Thursday, Jan. 3 @ 10 AM ET to discuss its acquisition activity in 2012. Maintain Overweight rating and $91 PT as we remain encouraged with the company's M&A activity, the rate parity increase, and we expect positive comments on tomorrow's call.”

Mednax closed on Monday at $79.52.

Latest Ratings for MD

Oct 2015SunTrust Robinson HumphreyMaintainsNeutral
Sep 2015Mizuho SecuritiesInitiates Coverage onBuy
Sep 2015Mizuho SecuritiesInitiates Coverage onBuy

View More Analyst Ratings for MD
View the Latest Analyst Ratings

Posted-In: Piper Jaffray & Co.Analyst Color Reiteration Analyst Ratings


Related Articles (MD)

View Comments and Join the Discussion!

Get Benzinga's Newsletters